Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Carbenoxolone-mediated cytotoxicity inhibits Vaccinia virus replication in a human keratinocyte cell line.

Haga IR, Simpson JL, Hawes PC, Beard PM.

Sci Rep. 2018 Nov 16;8(1):16956. doi: 10.1038/s41598-018-34732-w.

2.

Human papillomavirus (HPV) 16 E6 oncoprotein targets the Toll-like receptor pathway.

Oliveira LB, Haga IR, Villa LL.

J Gen Virol. 2018 Mar 29. doi: 10.1099/jgv.0.001057. [Epub ahead of print]

PMID:
29595418
3.

IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes.

Almine JF, O'Hare CA, Dunphy G, Haga IR, Naik RJ, Atrih A, Connolly DJ, Taylor J, Kelsall IR, Bowie AG, Beard PM, Unterholzner L.

Nat Commun. 2017 Feb 13;8:14392. doi: 10.1038/ncomms14392.

4.

Vaccinia Virus Uses Retromer-Independent Cellular Retrograde Transport Pathways To Facilitate the Wrapping of Intracellular Mature Virions during Virus Morphogenesis.

Harrison K, Haga IR, Pechenick Jowers T, Jasim S, Cintrat JC, Gillet D, Schmitt-John T, Digard P, Beard PM.

J Virol. 2016 Oct 28;90(22):10120-10132. doi: 10.1128/JVI.01464-16. Print 2016 Nov 15.

5.

RAB1A promotes Vaccinia virus replication by facilitating the production of intracellular enveloped virions.

Pechenick Jowers T, Featherstone RJ, Reynolds DK, Brown HK, James J, Prescott A, Haga IR, Beard PM.

Virology. 2015 Jan 15;475:66-73. doi: 10.1016/j.virol.2014.11.007. Epub 2014 Nov 26.

6.

A loss of function analysis of host factors influencing Vaccinia virus replication by RNA interference.

Beard PM, Griffiths SJ, Gonzalez O, Haga IR, Pechenick Jowers T, Reynolds DK, Wildenhain J, Tekotte H, Auer M, Tyers M, Ghazal P, Zimmer R, Haas J.

PLoS One. 2014 Jun 5;9(6):e98431. doi: 10.1371/journal.pone.0098431. eCollection 2014.

7.

TRAF2 facilitates vaccinia virus replication by promoting rapid virus entry.

Haga IR, Pechenick Jowers T, Griffiths SJ, Haas J, Beard PM.

J Virol. 2014 Apr;88(7):3664-77. doi: 10.1128/JVI.03013-13. Epub 2014 Jan 15.

8.

Polyinosinic acid is a ligand for toll-like receptor 3.

Marshall-Clarke S, Downes JE, Haga IR, Bowie AG, Borrow P, Pennock JL, Grencis RK, Rothwell P.

J Biol Chem. 2007 Aug 24;282(34):24759-66. Epub 2007 Jun 14.

9.

Evasion of innate immunity by vaccinia virus.

Haga IR, Bowie AG.

Parasitology. 2005;130 Suppl:S11-25. Review.

PMID:
16281988
10.

The role of Toll-like receptors in the host response to viruses.

Bowie AG, Haga IR.

Mol Immunol. 2005 May;42(8):859-67. Epub 2005 Jan 6. Review.

PMID:
15829275
11.

Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.

Stack J, Haga IR, Schröder M, Bartlett NW, Maloney G, Reading PC, Fitzgerald KA, Smith GL, Bowie AG.

J Exp Med. 2005 Mar 21;201(6):1007-18. Epub 2005 Mar 14.

12.

The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense.

Harte MT, Haga IR, Maloney G, Gray P, Reading PC, Bartlett NW, Smith GL, Bowie A, O'Neill LA.

J Exp Med. 2003 Feb 3;197(3):343-51.

13.

Identification of a bisegmented double-stranded RNA virus (Picobirnavirus) in faeces of giant anteaters (Myrmecophaga tridactyla).

Haga IR, Martins SS, Hosomi ST, Vicentini F, Tanaka H, Gatti MS.

Vet J. 1999 Nov;158(3):234-6. No abstract available.

PMID:
10558845

Supplemental Content

Support Center